UNSPSC 51292012: Fluoxetine hydrochloride

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C17H18F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01K63SUP8D, chemically known as (+) or (-)-n-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine but generally known as fluoxetine, which bears US NIH Compound Identifier 3386. European Medicines Agency schedules Fluoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07723MIG.

UNSPSC 51292012 Fluoxetine hydrochloride, a Commodity code, shows limited recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS—concerns procurement of naloxone and safe drug deactivation systems rather than fluoxetine, a selective serotonin reuptake inhibitor antidepressant. The mismatch suggests either a data-entry error in the code assignment or that fluoxetine procurement under this code is not currently active in tracked state and local solicitations.

Seminole County's naloxone and drug deactivation systems procurement (IFB posted June 30, 2026, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and may be FEMA-funded. No set-aside or preference designations were specified. No other recent opportunities under the fluoxetine code are present in the source material. Business development professionals should verify code assignment in state and local RFP and RFQ databases before treating this code as an active procurement target for fluoxetine or related pharmaceutical products.